ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,942.47
      1.26%
      US Tech 100
      20,762.73
      1.73%
      Dow Jones
      42,732.13
      0.80%
      Brent Oil
      76.495
      0.00%
      Bitcoin
      98,342.22
      0.14%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU

      6. Noxxon Pharma NV (ALTME) Quote

      Noxxon Pharma NV

      Noxxon Pharma NV (ALTME)

      EU
      0.07
      -0.003
      (-4.11%)
      Closed January 04 11:30AM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      0.07
      Bid
      0.068
      Ask
      0.0717
      Volume
      383,657
      0.069 Day's Range 0.0739
      0.0611 52 Week Range 0.436
      Market Cap
      1.992M
      Previous Close
      0.073
      Open
      0.0739
      Last Trade
      511
      @
      0.07
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      690,269
      Shares Outstanding
      28,453,373
      Dividend Yield
      -
      PE Ratio
      -0.30
      Earnings Per Share (EPS)
      -0.24
      Revenue
      17k
      Net Profit
      -6.74M

      About Noxxon Pharma NV

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.tmepharma.com
      Headquarters
      Berlin, Deu
      Founded
      -
      Noxxon Pharma NV is listed in the Pharmaceutical Preparations sector of the Euronext with ticker ALTME. The last closing price for Noxxon Pharma NV was 0.07 €. Over the last year, Noxxon Pharma NV shares have traded in a share price range of 0.0611 € to 0.436 €.

      Noxxon Pharma NV currently has 28,453,373 shares outstanding. The market capitalization of Noxxon Pharma NV is 2.08 € million. Noxxon Pharma NV has a price to earnings ratio (PE ratio) of -0.30.

      Ask ADVFN Intelligence (AI)

      ALTME Latest News

      More News

      TME Pharma kündigt strategischen Plan zur Externalisierung und Monetarisierung von NOX-E36, einem Produkt der zweiten klinischen Phase, an

      NOX-E36 bietet vielversprechende Entwicklungsmöglichkeiten für Augenkrankheiten mit einem hohen Bedarf an gut verträglichen Therapien mit antifibrotischer Wirkung Die antifibrotische...

      July 22 2024
      Business Wire

      TME Pharma Announces Strategic Plan to Externalize and Monetize Second Clinical Stage Asset NOX-E36

      NOX-E36 presents promising opportunity for development in eye diseases with a high need for well-tolerated therapies with anti-fibrotic effect Anti-fibrotic mode of action of NOX-E36 was...

      July 22 2024
      Business Wire
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.007-9.090909090910.0770.08280.0699509950.07405163DE
      4-0.011-13.58024691360.0810.110.06116768310.0755729DE
      12-0.0514-42.33937397030.12140.180.06116902690.11633897DE
      26-0.0818-53.88669301710.15180.180.06115198450.1288214DE
      52-0.169-70.71129707110.2390.4360.06116793570.22210562DE
      1560.028267.46411483250.04185.980.03983407690.32612778DE
      2600.028267.46411483250.04185.980.03983407690.32612778DE

      ALTME - Frequently Asked Questions (FAQ)

      What is the current Noxxon Pharma NV share price?
      The current share price of Noxxon Pharma NV is 0.07 €
      How many Noxxon Pharma NV shares are in issue?
      Noxxon Pharma NV has 28,453,373 shares in issue
      What is the market cap of Noxxon Pharma NV?
      The market capitalisation of Noxxon Pharma NV is EUR 2.08M
      What is the 1 year trading range for Noxxon Pharma NV share price?
      Noxxon Pharma NV has traded in the range of 0.0611 € to 0.436 € during the past year
      What is the PE ratio of Noxxon Pharma NV?
      The price to earnings ratio of Noxxon Pharma NV is -0.3
      What is the cash to sales ratio of Noxxon Pharma NV?
      The cash to sales ratio of Noxxon Pharma NV is 116.67
      What is the reporting currency for Noxxon Pharma NV?
      Noxxon Pharma NV reports financial results in EUR
      What is the latest annual turnover for Noxxon Pharma NV?
      The latest annual turnover of Noxxon Pharma NV is EUR 17k
      What is the latest annual profit for Noxxon Pharma NV?
      The latest annual profit of Noxxon Pharma NV is EUR -6.74M
      What is the registered address of Noxxon Pharma NV?
      The registered address for Noxxon Pharma NV is MAX-DOHRN-STRASSE 8-10, BERLIN, 10589
      What is the Noxxon Pharma NV website address?
      The website address for Noxxon Pharma NV is www.tmepharma.com
      Which industry sector does Noxxon Pharma NV operate in?
      Noxxon Pharma NV operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      MLFXOFinaxo
      0.895 €
      (43.20%)
      		500
      MLWEYWeya
      0.0175 €
      (34.62%)
      		5.1k
      POXELPoxel
      0.191 €
      (33.57%)
      		4.22M
      ALBIOBiosynex
      2.50 €
      (28.73%)
      		50.71k
      SEQUASequana medical NV
      3.02 €
      (23.27%)
      		1.05M
      BNBSTonner Drones
      0.0005 €
      (-50.00%)
      		524.03k
      ALAGOEPango SA
      0.127 €
      (-41.20%)
      		11.94M
      EIFDSTour Eiffel DS
      0.0032 €
      (-38.46%)
      		33.94k
      FINMFinanciere Marjos
      0.076 €
      (-36.13%)
      		1.4k
      ALALOAcheterLouerFR
      0.20 €
      (-33.33%)
      		90.63k
      ATOAtos SE
      0.0024 €
      (-4.00%)
      		1.53B
      BCPBanco Comercial Portugues SA
      0.4623 €
      (0.74%)
      		43.69M
      ALTDTonner Drones
      0.0118 €
      (-7.81%)
      		27.49M
      NEOENNeoen SA
      39.74 €
      (-0.15%)
      		21.76M
      ALVERVergnet
      0.002 €
      (0.00%)
      		16.8M

      Discussion

      View Full Feed
      flipper44 flipper44 4 minutes ago
      Do you happen to have a link to that example you gave?
      NWBO
      ty3 ty3 5 minutes ago
      Is that the company claiming to make water from air lol ? I think I posted a lol awhile back.
      CGAC
      OMOLIVES OMOLIVES 7 minutes ago
      Sorry to go off tilt..it's your fault. last one........killer:

      https://www.youtube.com/watch?v=wwIJk0C0xY0
      DiamondHealer95 DiamondHealer95 8 minutes ago
      I remember a time when dimes and mojo were wildly praised for their claim that this stock would hit $1-$3 by June. Just like Robert Sullivan on their Facebook page.

      It didn't.

      Stop considering their posts. They know next to nothing.

      By the way mojo - yo
      KBLB
      Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 8 minutes ago
      which position will the EMA take? (conventional), or will they go outside the box and follow in the steps of the authors, making the MABs relevant to the decision. The EMA has hinted that they are not happy with the MABs. The question might be, will the EMA approve a drug that can show partial pos
      AVXL
      BDEZ BDEZ 9 minutes ago
      A thug not even born here...smh.
      Huggy Bear Huggy Bear 9 minutes ago
      Actually that's Smokey Robinson, of the baby boomer generation, but what's an education worth nowadays?
      HMBL
      3331 3331 10 minutes ago
      OTC is entering a golden age in 2025 - Chartmaster.

      With news, BIEL could lead the way!
      BIEL
      skitahoe skitahoe 10 minutes ago
      While I know nothing about the specific trial, as I see it if the regulators accept the protocol of a specific trial they're also accepting the fact that if results warrant, they'll approve the drugs in the trial. It's up to the company to establish the acceptance criteria, which the regulator acce
      NWBO
      boi568 boi568 11 minutes ago
      The regulatory authorities don't care who is speaking at a conference, they just care what is submitted as part of a drug application.

      I happen to think eyewitness testimony is a gimmick that will not persuade cynical executives.
      AVXL
      Acme Investments Acme Investments 15 minutes ago
      People just don't understand how the Otc works!! If they say it runs it runs!! Doesn't matter if you like the fundamentals!!
      AITX
      DiamondHealer95 DiamondHealer95 15 minutes ago
      There it is! The MONDAY COULD BE EXCITING for the 457th time in 13 months!

      85%+ Monday PR releases and this user is betting on an update at anytime (no shit) and is picking... MONDAY!

      That folks is what we call a sure bet and staying the obvious.

      That bei
      KBLB
      SSKILLZ1 SSKILLZ1 15 minutes ago
      Pick 4 Contest #21 Contest Info. In.

      Hope everyone enjoys. Hope this helps.

      https://investorshub.advfn.com/Pick-4-Contest-No-21-46064
      SSKILLZ1 SSKILLZ1 15 minutes ago
      Pick 4 Contest #21 Contest Info. In.

      Hope everyone enjoys. Hope this helps.

      https://investorshub.advfn.com/Pick-4-Contest-No-21-46064
      Bob1968 Bob1968 16 minutes ago
      Interview with Intel CEO

      https://www.youtube.com/watch?v=DpJqRHFYUqk
      INTC
      Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 16 minutes ago
      I just bought a beautiful sporty looking SUV and it cost me almost 50K come on avxl I'm counting on you I got to get that money back LOL

      Same here with the red 'Stang. Let's make some cash!
      AVXL
      mrfence mrfence 17 minutes ago
      Don't let the paid shills fluster yah. Just know when they come at yah it's because you're speaking valid truth. That threatens their failing ruse. Oh, and thanks to JPS lawyers for making the case for commons while trying to rob them a second time :-D
      dinogreeves dinogreeves 17 minutes ago
      Hindenburg has targeted CARVANA now CV*NA. Citron short seller is backing NBI*S and pounding the table saying it is severely undervalued and a hidden gem, sees short term 60 dollars. I can't wait to see them buried alive on SMCI, provided that they haven't covered yet, betting they have already.
      SMCI
      dstock07734 dstock07734 18 minutes ago
      Gary,

      About the number of compassionate use patients, I think there are a lot. I went through this before.

      You can see in June 2023 Dr. Bosch mentioned about 600 patients in his presentation while at the end of August Les mentioned that about 800 patients received the t
      NWBO
      DiamondHealer95 DiamondHealer95 18 minutes ago
      Earth to mojo? Can you defend your position? No? Thought so.

      Stop posting.
      KBLB
      flipper44 flipper44 18 minutes ago
      Revimmune
      NWBO
      Dabeav Dabeav 21 minutes ago
      Fi Fiddy!!! Coming soon!
      FNMA
      SSKILLZ1 SSKILLZ1 21 minutes ago
      Every Stock with Starting Price and # of Shares (In Alphabetical Order)

      Commentary: This chart will help everyone set up there imaginary portfolios if they so desire. It gives the starting prices of each stock and the # of shares. Hope this helps.
      [pre]
      Symbol # Of Sha
      AES AMRN APLD
      quester614 quester614 22 minutes ago
      At least we know there is no decent lawyer here. LOLOLOL Crypto may be soon.

      https://investorshub.advfn.com/uimage/uploads/2025/1/4/gxdttScreenshot_2025-01-04_11.23.03_PM.png
      XERI

      Your Recent History

      EU
      ALTME
      Noxxon Pharma NV
      BIT
      P1U1C1
      BNP Paribas Issuance
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads